LivaNova (NASDAQ:LIVN – Get Free Report) updated its FY 2024 earnings guidance on Wednesday. The company provided EPS guidance of 3.050-3.150 for the period, compared to the consensus EPS estimate of 3.000. The company issued revenue guidance of $1.2 billion-$1.2 billion, compared to the consensus revenue estimate of $1.2 billion. LivaNova also updated its FY24 […]
Related Keywords
Robertw Baird , , Needham Company , Barclays , Get Free Report , Moderate Buy , Advanced Circulatory Support , Livanova Daily , Livanova , Nasdaq Livn , Livn , Medical , Guidance , Earnings , Preannouncement ,
vimarsana.com © 2020. All Rights Reserved.